Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROstate CAncer Radiotherapy: Its Real Impact on Bowel Symptoms & Quality of Life Today, Measured by the EORTC QLQ C30 & Specific PRT20 Module.

NCT05880446 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT05880446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05880446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROstate CAncer Radiotherapy: Its Real Impact on Bowel Symptoms & Quality of Life Today, Measured by the EORTC QLQ C30 & Specific PRT20 Module.
Lead sponsor
Jules Bordet Institute
Phase
Not applicable
Overall status
Completed
Start date
October 6, 2023
Completion date
March 29, 2024
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bowel dysfunction, prostate cancer, quality of life, radiotherapy side effect